DNB Investors Have Chance to Join Dun & Bradstreet Fraud Lawsuit
On September 25, 2026, the Rosen Law Firm, a prominent firm advocating for investor rights, announced a class action lawsuit against Dun & Bradstreet Holdings, Inc. (NYSE: DNB). This litigation aims to address significant allegations of securities fraud that have arisen from the company’s actions over the past few years. The case particularly targets those who sold shares of Dun & Bradstreet Holdings, exchanged shares in a specific merger, or held onto their shares during a critical period in 2025.
The firm has called for individuals or entities that sold shares from May 13, 2025, to August 26, 2025, or those who were involved during the merger on August 26, 2025, with affiliates of Clearlake Capital Group, to come forward. If any of these parties sold shares, are eligible according to the defined Record Date of May 9, 2025, or engaged with the merger in any capacity, they may have an opportunity to be compensated without incurring any legal fees or expenses upfront, courtesy of a contingency fee arrangement.
Investors are urged to act quickly, as the deadline for appointing a lead plaintiff is set for November 10, 2026. The lead plaintiff would represent the interests of all impacted investors throughout the legal proceedings. The Rosen Law Firm emphasizes the importance of choosing legal representation carefully, especially referring to their extensive experience and success rate in similar cases. The firm has garnered attention for achieving one of the largest settlements in a securities class action lawsuit, notably against a Chinese company, and holds a strong record in securing settlements for investors.
The lawsuit centers around allegations that Dun & Bradstreet misrepresented critical information regarding their merger and the true state of their financials. Specifically, claims have been made that the company provided misleading statements and omitted significant facts that would have impacted investors' decisions at the time. The firm argues that the merge was presented as a typical strategic maneuver while failing to disclose key internal interests and past valuations that suggested there were better alternatives available than a full company sale.
Moreover, it’s noted that the documentation leading up to this merger, particularly a definitive proxy statement sent out in May 2025, fell short in detailing these crucial issues. There were concerns that this proxy statement maintained a misleading narrative about the company’s financial situation, decisions made by the Board of Directors, and undisclosed relationships between company executives and their financial and legal advisors.
The Rosen Law Firm is keen on ensuring that every affected investor knows their rights and the legal pathways available to them. They stress that potential plaintiffs can choose to remain passive at this stage if they wish but strongly encourage impacted investors to consider joining this lawsuit to ensure they receive any financial restitution they may be entitled to. As the case unfolds, further developments are expected, and anyone impacted is prompted to stay informed and proactively engage with legal counsel.
In conclusion, if you believe you might be entitled to participate in the class action against Dun & Bradstreet, you can visit the Rosen Law Firm’s dedicated web page or contact their office directly for more information. The firm outlines the necessary steps for joining the class action, reiterating that interested parties are not represented unless they opt to retain counsel and join the case actively. This case presents a critical opportunity for current and former investors in Dun & Bradstreet Holdings, Inc. to potentially recover losses incurred due to alleged misrepresentation and fraud by the company.